Svoronos Dawn

The estimated Net Worth of Svoronos Dawn is at least $4 Million dollars dollars as of 05/18/2022. Svoronos Dawn is the Director of Adverum Biotechnologies Inc. Svoronos Dawn owns over 20,000 shares of Adverum Biotechnologies Inc stock worth over $16,928.00. Svoronos Dawn is the Director of Global Blood Therapeutics Inc. Svoronos Dawn owns over 2,256 shares of Global Blood Therapeutics Inc stock worth over $62,787.19. Svoronos Dawn is the Director of Medivation Inc. Svoronos Dawn owns over 18,234 shares of Medivation Inc stock worth over $1 Million dollars . Svoronos Dawn is the Director of PTC Therapeutics Inc. Svoronos Dawn owns over 29,755 shares of PTC Therapeutics Inc stock worth over $922,107.45. Svoronos Dawn is the Director of Xenon Pharmaceuticals Inc. Svoronos Dawn owns over 50,000 shares of Xenon Pharmaceuticals Inc stock worth over $2 Million dollars .

Svoronos Dawn mailing address: C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105

Insider Roles

Name	Transaction Date	Position
Global Blood Therapeutics Inc	2018-12-19	director
PTC Therapeutics Inc	2017-01-03	director
Xenon Pharmaceuticals Inc	2016-09-27	director
Endocyte Inc	2018-12-21	director
Medivation Inc	2016-09-28	director
Adverum Biotechnologies Inc	2020-12-09	director

EMBED

SAVE

Svoronos Dawn trading performance

Average Relative Return

237.74%

Average relative return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

Svoronos Dawn trading performance analysis

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Relative Return(%)	29.71	12.22	35.45	237.74	222.49	303.85
Relative Return to S&P 500(%)	28.35	9.01	26.54	223.23	206.15	274

Svoronos Dawn trading transactions

Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
ADVM	Adverum Biotechnologies Inc	$0.86	Svoronos Dawn	Director	2021-03-31	Buy	20,000	100%	$10.02	$200,400	20,000	-91.47%	-	0	At Loss	83.60
GBT	Global Blood Therapeutics Inc	$28.13	Svoronos Dawn	Director	2020-06-19	Sell	2,544	-53%	$63.94	$162,663	2,256	-56.01%	-	0	At Loss	1,811.76
XENE	Xenon Pharmaceuticals Inc	$31.23	Svoronos Dawn	Director	2017-08-14	Buy	50,000	100%	$2.82	$141,000	50,000	1,007.45%	-	0	At Loss	1,624.77
PTCT	PTC Therapeutics Inc	$31.40	Svoronos Dawn	Director	2017-05-23	Buy	25,000	100%	$13.49	$337,250	25,000	132.77%	-	0	At Loss	2,210.77
MDVN	Medivation Inc	$81.44	Svoronos Dawn	Director	2016-03-14	Sell	6,000	-24.76%	$38.90	$233,400	18,234	109.36%	-	0	At Loss	13,513.23
MDVN	Medivation Inc	$81.44	Svoronos Dawn	Director	2015-09-08	Sell	3,100	-20.37%	$89.15	$276,365	24,234	-8.65%	-	0	At Loss	13,513.23
MDVN	Medivation Inc	$81.44	Svoronos Dawn	Director	2015-03-02	Sell	3,350	-19.72%	$119.75	$401,162	27,278	-31.99%	-	0	At Loss	13,513.23

Total 7

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Svoronos Dawn personal network

Name	Position	Linked company

Get Premium to unlock powerful stock data

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.